Changes in radioiodine turnover in patients with autonomous thyroid adenoma treated with percutaneous ethanol injection

被引:0
作者
Paracchi, A
Reschini, E
Ferrari, C
Ciocia, G
Castellani, M
机构
[1] Osped Maggiore, Dept Nucl Med, I-20122 Milan, Italy
[2] Osped Fatebenefratelli, Dept Endocrinol, Milan, Italy
[3] Osped Fatebenefratelli, Dept Nucl Med, Milan, Italy
[4] Osped S Pio X, Dept Endocrinol, Milan, Italy
关键词
autonomous thyroid adenoma; percutaneous ethanol injection; ethanol injection;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
In 24 patients with autonomous thyroid adenoma, we studied the hormonal pattern (free thyroxine, free triiodothyronine and thyroid stimulating hormone) and markers of radioiodine turnover before and after nodule ablation with percutaneous ethanol injection. Methods: The hormonal pattern was studied before treatment and at various intervals after nodule ablation. Changes in radioiodine turnover were studied measuring I-131 protein-bound iodine and the biologic half-life of radioiodine in the thyroid (calculated from thyroid uptake at 24 and 48 hr) before and after ethanol treatment. Results: The hormonal pattern was normalized by treatment in all patients and remained normal for the follow-up period. Before treatment, protein-bound I-131 was elevated in all patients but 4; after treatment, it normalized in 15 patients with the disappearance of the adenoma on scintigraphy. In the remaining 9 patients with only partial nodule destruction on scintigraphy, protein-bound I-131 remained elevated although markedly reduced. Biologic half-life was shortened in 18 of 24 patients before treatment; after treatment, it was normal in 18 of 24 patients (13 of 15 with complete nodule ablation and 5 of 9 with partial ablation). Conclusion: Ethanol treatment normalized the hormonal pattern in all patients. Measures of radioiodine turnover were better markers of residual disease in that they normalized in almost all patients with complete nodule ablation, whereas they remained abnormal in a high proportion of patients with incomplete ablation. Thyroid hormones remained normal over a follow-up period of 3-7 yr in all patients.
引用
收藏
页码:1012 / 1016
页数:5
相关论文
共 50 条
  • [41] Percutaneous ethanol injection in thyroid nodular pathology and metastatic cervical adenopathies: A systematic review, meta-analysis and economic evaluation
    Leon-Salas, Beatriz
    Hernandez-Yumara, Aranzazu
    Infante-Ventura, Diego
    Castellano, Aythami de Armas
    Hernandez, Yadira Gonzalez
    Linertova, Renata
    Santana, Teresa Tellez
    de Pablos-Velasco, Pedro
    Trujillo-Martin, Maria M.
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2023, 70 (09): : 572 - 583
  • [42] A Clinical Study of the Change of Stiffness of Cystic Thyroid Nodules After Percutaneous Ethanol Injection with 2D-ShearWave™ Elastography
    Qiao, Xiao-Hui
    Feng, Xiao-Yun
    Bai, Min
    Zhang, Jia-Jie
    Gao, Feng
    Li, Fan
    Zhang, Hui-Ping
    Du, Lian-Fang
    Xing, Jin-Fang
    JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS, 2017, 7 (06) : 1121 - 1125
  • [43] Hepatic resection and percutaneous ethanol injection for the treatment of selected patients with more than one hepatocellular carcinoma
    Belli, G
    Iannelli, A
    Romano, G
    Marano, I
    EUROPEAN JOURNAL OF SURGERY, 1999, 165 (07) : 647 - 651
  • [44] Serum concentrations of matrix metalloproteinase-9 and vascular endothelial growth factor affect the prognosis of primary hepatic carcinoma patients treated with percutaneous ethanol injection
    Zhang, Yan
    Zhang, Meiwu
    Fan, Xiaoxiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (09): : 16036 - 16042
  • [45] Long-term efficacy and safety of percutaneous ethanol injection (PEI) in cystic thyroid nodules: A systematic review and meta-analysis
    Cesareo, Roberto
    Tabacco, Gaia
    Naciu, Anda Mihaela
    Crescenzi, Anna
    Bernardi, Stella
    Romanelli, Francesco
    Deandrea, Maurilio
    Trimboli, Pierpaolo
    Palermo, Andrea
    Castellana, Marco
    CLINICAL ENDOCRINOLOGY, 2022, 96 (02) : 97 - 106
  • [46] Flash echo gray scale imaging with subtraction in assessment of small hepatocellular carcinoma treated with percutaneous ethanol injection - Preliminary report
    Wang, JH
    Lu, SN
    Changchien, CS
    Lee, CM
    Tung, HD
    Chen, TM
    JOURNAL OF ULTRASOUND IN MEDICINE, 2001, 20 (05) : 539 - 544
  • [47] Effectiveness of percutaneous ethanol injection therapy in benign nodular and cystic thyroid diseases: Long-term follow-up experience
    Lee, SJ
    Ahn, IM
    ENDOCRINE JOURNAL, 2005, 52 (04) : 455 - 462
  • [48] PERCUTANEOUS ETHANOL INJECTION UNDER SONOGRAPHIC GUIDANCE OF HEPATOCELLULAR-CARCINOMA IN COMPENSATED AND DECOMPENSATED CIRRHOTIC-PATIENTS
    GIORGIO, A
    TARANTINO, L
    FRANCICA, G
    SCALA, V
    MARINIELLO, N
    ALOISIO, T
    JOURNAL OF ULTRASOUND IN MEDICINE, 1992, 11 (11) : 587 - 595
  • [49] Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy
    Pompili, M
    Rapaccini, GL
    Covino, M
    Pignataro, G
    Caturelli, E
    Siena, DA
    Villani, MR
    Cedrone, A
    Gasbarrini, G
    CANCER, 2001, 92 (01) : 126 - 135
  • [50] TREATMENT OF SMALL HEPATOCELLULAR-CARCINOMA WITH PERCUTANEOUS ETHANOL INJECTION - ANALYSIS OF PROGNOSTIC FACTORS IN 105 WESTERN PATIENTS
    LENCIONI, R
    BARTOLOZZI, C
    CARMELLA, D
    PAOLICCHI, A
    CARRAI, M
    MALTINTI, G
    CAPRIA, A
    TAFI, A
    CONTE, PF
    BEVILACQUA, G
    CANCER, 1995, 76 (10) : 1737 - 1746